Region — International. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Retinal (Retinaldehyde)
Research reference — not for sale

Retinal (Retinaldehyde)

A
lead outcome
Topical: fine lines / photoaging appearance
grades vary by outcome ↓
Small molecule (non-peptide)
also called — retinaldehyde · all-trans-retinal · vitamin A aldehyde · retinene · INCI: Retinal · (NOT a synonym for retinol — one conversion step closer to the active form)
skin appearance (cosmetic)fine lines and photoaging appearancetexture (appearance of smoother skin)acne-prone skin appearanceantibacterial (reference-science)

This is an independent evidence reference. Vallydia does not currently sell a retinaldehyde product; this entry supports the retinol vs retinal comparison and the wider retinoid cluster.

In brief

Retinal — retinaldehyde on a longer label — is the retinoid one honest step ahead of retinol. Where retinol must convert twice inside the skin to become retinoic acid (the active form that drives renewal), retinal converts just once. That single-step head start makes it more potent than retinol for the look of fine lines and texture, while staying gentler than prescription tretinoin (which is retinoic acid applied directly). Graded A for the appearance of photoaged skin. It carries one genuine bonus the other cosmetic retinoids don't: a documented antibacterial property, which is why it appears in acne-appearance formulas. In the EU it is a distinct molecule from retinol and is not caught by the 0.3% retinol concentration cap. Honest limit: it is still a retinoid — it can irritate, it needs daily SPF, and "treats acne" or "reverses ageing" remain medical claims it cannot make. See the full comparison in retinol vs retinal.

Legal standing, by region
European Union
Lawful cosmetic ingredient (not under the retinol concentration cap)

Retinal (Retinaldehyde) is a lawful cosmetic ingredient in the EU under Regulation (EC) 1223/2009. It is a DISTINCT molecule from retinol: the Annex III concentration restriction introduced by Commission Regulation (EU) 2024/996 (max 0.3% Retinol Equivalent in face/hands leave-on) names Retinol, Retinyl Acetate and Retinyl Palmitate — it does NOT list Retinaldehyde, which therefore is not subject to that 0.3% RE cap. Retinaldehyde is commonly formulated up to about 0.05–0.1%. (Legal status of a specific formula should still be confirmed against the current consolidated regulation before market placement.)

United Kingdom
Lawful cosmetic ingredient

UK Cosmetics Regulation (retained EU law) tracks Regulation 1223/2009; retinaldehyde is a lawful cosmetic ingredient and, like in the EU, is not named in the retinol/retinyl-ester Annex III concentration entry.

United States
Lawful cosmetic ingredient

Retinaldehyde is a lawful cosmetic ingredient in the US, not subject to concentration limits at cosmetic use. Tretinoin (all-trans retinoic acid) is a separate molecule and prescription-only.

International
Varies by jurisdiction

Broadly available as a cosmetic retinoid; producers often standardise on EU-aligned formulations. As a distinct molecule from retinol, it is generally outside the retinol-specific concentration caps some markets apply.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Topical: fine lines / photoaging appearance
Appearance-level, not a wrinkle treatment; still a retinoid and can irritate (less than tretinoin, and vehicle/stability matter as much as concentration). Daily SPF is non-negotiable — retinoids raise sun sensitivity
Controlled clinical studies of topical retinaldehyde at 0.05–0.1% show improvement in the appearance of fine lines, roughness and photoaged skin. Creidi's profilometric study (J Am Acad Dermatol 1998) measured reduced photodamage after topical retinaldehyde, comparable in direction to retinoic acid; a 2018 randomized double-blind trial (J Cosmet Dermatol) confirmed efficacy and tolerability of 0.05% and 0.1% creams. Retinal converts to retinoic acid in a single step (retinol needs two), making it more potent than retinol while remaining better tolerated than prescription tretinoin. · Softer-looking fine lines and smoother texture over 8–12 weeks — faster and stronger than retinol at comparable tolerability, gentler than prescription tretinoin
A
Skin texture & renewal appearance
Requires consistent use over months; benefit is the appearance of renewal, not a medical resurfacing claim
The single-step conversion to retinoic acid drives visible surface renewal; controlled studies on skin roughness show a smoother, fresher- looking surface (Didierjean/Saurat, Dermatology 1999; Creidi 1998) · Fresher-, smoother-looking skin surface
A
Acne-prone skin appearance
Cosmetic appearance only — "treats acne" is medical territory (prescription retinoids/antibiotics); the antibacterial finding stays in the reference layer, not a drug claim
Studies report retinaldehyde improves the look of acne-prone skin, supported by a property unusual among cosmetic retinoids — documented antibacterial activity against Cutibacterium acnes (Pechère, Dermatology 2002) · Clearer-looking, less blemish-prone appearance
B
Antibacterial property (differentiator vs retinol)
Reference-science only. Framed in cosmetic claims as appearance, never as "kills bacteria" or an antimicrobial treatment claim
Retinaldehyde shows antibacterial activity in vitro against Cutibacterium acnes — a trait retinol does not share (Pechère et al., Dermatology 2002). It is the mechanistic basis for its acne-appearance use and its main point of difference from retinol · Part of the acne-appearance story; a genuine differentiator
B
Hyperpigmentation appearance
Appearance only; smaller than prescription options and slower than dedicated tone actives
Retinoid-driven surface renewal supports the look of a more even tone, as with retinol; effect is modest at cosmetic concentrations · More even-looking tone
B
"Treats acne / reverses ageing / builds or stimulates collagen"
Retinoic acid (tretinoin) is the regulated drug; a cosmetic aldehyde precursor cannot carry treatment claims
Treatment and structure/function claims. Retinal's mechanism (conversion to retinoic acid, receptor binding, antibacterial activity) is reference- layer science; the cosmetic claim is appearance only · Outside cosmetic scope — firewalled out
D
Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Retinal (Retinaldehyde) changes - nothing else.

One ingredient, one purpose. No marketing, no sharing. Unsubscribe anytime. See our privacy policy.

Cosmetic claims boundary
✓ Allowed (appearance / feel)
  • for the appearance of softer-looking fine lines
  • for the appearance of smoother, fresher-looking texture
  • for the appearance of clearer, less blemish-prone skin
  • for the appearance of a more even-looking tone
  • a more potent cosmetic retinoid than retinol, gentler than prescription tretinoin
✕ Not allowed (medicinal)
  • treats acne
  • reverses ageing
  • builds collagen
  • stimulates collagen synthesis
  • treats wrinkles
  • kills bacteria
  • antimicrobial treatment

The medicinal-sounding science stays in the reference section; product copy speaks only to appearance/feel (Reg 655/2013). Different fields, never merged.

Identity

Retinal (INCI: Retinal; also retinaldehyde, vitamin A aldehyde) is a vitamin A derivative and a true retinoid. It sits on the conversion pathway between retinol and retinoic acid: retinol → retinal → retinoic acid. Because it is only one enzymatic step from the active retinoic acid, it is more efficient than retinol — which sits two steps back — and therefore, gram for gram, more potent for the appearance of renewal, while remaining a cosmetic ingredient rather than a prescription drug.

It is a distinct molecule, and the naming trips people up. Retinol is not a synonym — it is one conversion step further from the active form, and gentler as a result. Tretinoin (retinoic acid) is not a synonym — that is the prescription active itself, a different regulatory class. Retinyl esters (retinyl palmitate and similar) sit further back still. The honest, side-by-side version of this is laid out in our retinol vs retinal comparison.

The conversion pathway, plainly

Topical vitamin A works by ultimately becoming retinoic acid in the skin, which binds retinoid receptors and drives the renewal program — faster cell turnover and the look of smoother texture and softened fine lines. The forms differ only by how many conversion steps stand between them and that active endpoint:

  • Retinyl esters → retinol → retinal → retinoic acid (three steps — weakest)
  • Retinol → retinal → retinoic acid (two steps)
  • Retinal (retinaldehyde) → retinoic acid (one step — the most potent non-prescription form)
  • Tretinoin = retinoic acid already (prescription; no conversion)

Fewer steps means more of the applied dose reaches the active form, so retinal delivers more visible renewal than retinol at comparable tolerability — the reason it is often called "the strongest retinoid you can buy without a prescription." Its second, less-advertised trait: retinaldehyde has antibacterial activity against Cutibacterium acnes in studies, unusual among cosmetic retinoids, which is why it turns up in formulas aimed at the appearance of acne-prone skin. As with every retinoid, it raises sun sensitivity — daily SPF is non-negotiable — and the renewal, receptor-binding and antibacterial mechanisms stay in the reference layer; the cosmetic claim is appearance only.

Development & history

  • Retinaldehyde has been studied in dermatology since the 1990s as a better-tolerated, cosmetically-available step up from retinol, with the Geneva group (Saurat and colleagues) characterising its topical activity and metabolism.
  • Its defining feature is its position on the conversion pathway: one step from retinoic acid, so more potent than retinol without prescription status.
  • It is distinctive among cosmetic retinoids for a documented antibacterial property against Cutibacterium acnes, relevant to acne-appearance formulas.
  • Search interest has climbed sharply as "retinal vs retinol" became a mainstream skincare question — reflecting real demand for a clear, honest comparison rather than the marketing "10× stronger" shorthand.
Chemical identifiers

Cross-reference identifiers for the authoritative external databases — not a recipe, and nothing about how to use it.

PubChem CID638015
InChIKeyNCYCYZXNIZJOKI-OVSJKPMPSA-N
SMILESCC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=O)/C)/C
UNIIRR725D715M

via PubChem exact-name match (Retinaldehyde), CID 638015 · high confidence

Sources — 5 cited
01Creidi P, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol. 1998. doi:10.1016/s0190-9622(98)70270-1.
02Pechère M, et al. The Antibacterial Activity of Topical Retinoids: The Case of Retinaldehyde. Dermatology. 2002; 205(2):153-158. doi:10.1159/000063903.
03Didierjean L, et al. Biological Activities of Topical Retinaldehyde. Dermatology. 1999. doi:10.1159/000051373.
04Kwon HS, et al. Efficacy and safety of retinaldehyde 0.1% and 0.05% creams used to treat photoaged skin: a randomized, double-blind controlled trial. J Cosmet Dermatol. 2018. doi:10.1111/jocd.12551.
05Creidi P, et al. Clinical Use of Topical Retinaldehyde on Photoaged Skin. Dermatology. 1999. doi:10.1159/000051379.
Updated 2026-07-27

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
Retinol (Vitamin A)A
Small molecule (non-peptide)
BakuchiolB
Small molecule (non-peptide)
Niacinamide (Vitamin B3)A
Small molecule (non-peptide)
Explore by goal
Skin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

RegionInternational
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen data
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.